Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol

Although acute psychotic symptoms are often reduced by antipsychotic treatment, many patients with schizophrenia are impaired in daily functioning due to the persistence of negative and cognitive symptoms. Raloxifene, a Selective Estrogen Receptor Modulator (SERM) has been shown to be an effective a...

Descripción completa

Detalles Bibliográficos
Autores principales: Brand, Bodyl A., de Boer, Janna N., Oude Ophuis, Sebastianus B.J., Slot, Margot I.E., De Wilde, Bieke, Catthoor, Kirsten C.E.E.R., Goverde, Angelique J., Bakker, P. Roberto, Marcelis, Machteld C., Grootens, Koen P., Luykx, Jurjen J., Heringa, Sophie M., Weickert, Cynthia Shannon, Sommer, Iris E.C., Weickert, Thomas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750317/
https://www.ncbi.nlm.nih.gov/pubmed/33364517
http://dx.doi.org/10.1016/j.conctc.2020.100681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750317/
https://www.ncbi.nlm.nih.gov/pubmed/33364517
http://dx.doi.org/10.1016/j.conctc.2020.100681

Ejemplares similares